CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business … – Nasdaq
|
CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business …
Nasdaq BASEL, Switzerland and CAMBRIDGE, Mass., May 11, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics, (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported … Crispr Therapeutics AG (CRSP) Insider Tyler Dylan-Hyde Sells 10177 Shares Analysts Anticipate Crispr Therapeutics AG (CRSP) to Post ($0.51) EPS Casebia Therapeutics Expands Leadership Team | Business Wire |
